Journal · Biochemistry · Updated 21 November 2026
Molecular and Cellular Biochemistry
Read Molecular and Cellular Biochemistry articles on DeepDyve. No university library needed.
Molecular and Cellular Biochemistry covers the biochemistry of cells in health and disease, from gene editing and cell signaling to the molecular mechanisms of cancer, heart failure, diabetes and liver disease. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Molecular and Cellular Biochemistry at a glance
- Full title
- Molecular and Cellular Biochemistry
- Abbreviation (NLM)
- Mol Cell Biochem
- Publisher
- Springer Nature
- Print ISSN
- 0300-8177
- Online ISSN (eISSN)
- 1573-4919
- First published
- 1973
- Subjects
- Biochemistry, Cell Biology, Molecular Biology
- Access model
- Hybrid (20% free to read in 2026)
Ways to access Molecular and Cellular Biochemistry
20% of the articles Molecular and Cellular Biochemistry published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 20% of Molecular and Cellular Biochemistry articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Molecular and Cellular Biochemistry. Check its journal list and whether it offers remote access.
- DeepDyve. Read Molecular and Cellular Biochemistry articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Molecular and Cellular Biochemistry’s 2025 Journal Impact Factor is 4.7, and its 5-year Impact Factor is 4.4.
4.7
Journal Impact Factor (2025)
4.4
5-year Impact Factor (2025)
22 days
Median time to first decision
1.5M
Downloads (2025)
Source: journal metrics on the Molecular and Cellular Biochemistry homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Molecular and Cellular Biochemistry research worth reading
Published January to June 2026. Summaries describe what the authors report.
-
Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights
The authors synthesized two benzimidazole-based compounds and report that one, 3b, was highly toxic to liver and breast cancer cells (IC50 values of 10.83 and 11.55 µM), raising oxidative stress and shifting apoptosis genes in breast cancer cells.
Kundu et al. · Molecular and Cellular Biochemistry, published online June 23, 2026 · DOI 10.1007/s11010-026-05600-3
-
Lactylation-mitochondria axis in chronic kidney disease: metabolic reprogramming, epigenetic dysregulation, and therapeutic potential
Gan and colleagues review how impaired lactate metabolism in kidney tubular cells can lead to lactic acid buildup, inflammation and mitochondrial dysfunction, and how the resulting lactylation modifications may offer new therapeutic targets in kidney disease.
Gan et al. · Molecular and Cellular Biochemistry, published online January 9, 2026 · DOI 10.1007/s11010-025-05465-y
-
Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice
Yuan and colleagues report that 8 weeks of semaglutide in APP/PS1 mice was associated with improved cognition, reduced Aβ deposition and lower inflammasome and TLR4/NF-κB signaling proteins, accompanied by partial preservation of blood-brain barrier integrity.
Yuan et al. · Molecular and Cellular Biochemistry, published online May 13, 2026 · DOI 10.1007/s11010-026-05568-0
-
Gomisin A and metformin co-treatment attenuates diabetic nephropathy and cardiovascular dysfunction by modulating the AGE/RAGE pathway in a diabetic rat model
In a diabetic model, Nayak and colleagues report that Gomisin A combined with metformin improved glycemic control and renal function more than Gomisin A alone, also preventing renal hypertrophy and modulating the AGE/RAGE pathway, and suggest the two work synergistically against nephropathy and cardiovascular disease.
Nayak et al. · Molecular and Cellular Biochemistry, published online February 14, 2026 · DOI 10.1007/s11010-026-05497-y
-
The central role of mitochondrial dysfunction in neurodegeneration: implications for therapy
Raafat and colleagues review how mitochondrial dysfunction contributes to Alzheimer’s, Parkinson’s and other neurodegenerative diseases, and note that mitochondria-targeted therapies often protect neurons in experimental models while clinical findings have been inconsistent.
Raafat et al. · Molecular and Cellular Biochemistry, published online April 27, 2026 · DOI 10.1007/s11010-026-05542-w
See every Molecular and Cellular Biochemistry article on DeepDyve
Related journals
Questions about Molecular and Cellular Biochemistry
How can I read Molecular and Cellular Biochemistry articles without a subscription?
20% of Molecular and Cellular Biochemistry articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Molecular and Cellular Biochemistry articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Molecular and Cellular Biochemistry?
Molecular and Cellular Biochemistry’s NLM (PubMed) abbreviation is Mol Cell Biochem.
What is the ISSN of Molecular and Cellular Biochemistry?
The print ISSN is 0300-8177 and the online ISSN is 1573-4919.
What is the impact factor of Molecular and Cellular Biochemistry?
Molecular and Cellular Biochemistry’s Journal Impact Factor is 4.7 (2025), and its 5-year Impact Factor is 4.4, according to Springer Nature’s published metrics.
Is Molecular and Cellular Biochemistry open access?
Molecular and Cellular Biochemistry is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 64 of 323 Molecular and Cellular Biochemistry articles (20%) carry a Creative Commons license, per Crossref.
Molecular and Cellular Biochemistry articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Molecular and Cellular Biochemistry today
One month free, then less than $2 a day. Molecular and Cellular Biochemistry, plus millions of articles from thousands of journals.





